Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Coronary Sinus Reducer for Treatment of Refractory Angina - COSIRA

This study has been completed.
Information provided by (Responsible Party):
Neovasc Inc. Identifier:
First received: September 13, 2010
Last updated: November 22, 2013
Last verified: November 2013